Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Zhiqiang Wu, Kaichao Feng, Yang Liu, Xiang Li, Weidong Han, Qian Mei, Xiaolei Li, Malcolm V. Brock, Mingzhou Guo, Yan Zhang, Su-Xia Li, Lu Shi, Jing Nie, Meixia Chen
Publikováno v:
International Journal of Cancer
The pressing need for improved therapeutic outcomes provides a good rationale for identifying effective strategies for alimentary tract (AT) cancer treatment. The potential re‐sensitivity property to chemo‐ and immunotherapy of low‐dose decitab
Autor:
Weibo Zhu, Juan Tong, Yongsheng Han, Zuyi Wang, Kaiyang Ding, Wen Yao, Yue Wu, Kaiding Song, Baolin Tang, Hui-Zhi Yang, Liangquan Geng, Chenhui Luo, Changcheng Zheng, Xiaoyu Zhu, Xingbing Wang, Xin Liu, Lei Zhang, Xiang Wan, Xuhan Zhang, Zimin Sun, Huilan Liu, Jingsheng Wu
Publikováno v:
International Journal of Cancer
Cord blood transplantation (CBT) is an effective option for treating hematological malignancies, but graft failure (GF) remains the primary cause of therapy failure. Thus, based on myeloablative conditioning (MAC) of busulfan with cyclophosphamide (B
Autor:
Toshiyuki Tanahashi, Masako Kanematsu, Siqin Gaowa, Kazuhiro Yoshida, Junko Kato, Nobuhisa Matsuhashi, Ryutaro Mori, Manabu Futamura
Publikováno v:
International Journal of Cancer
Targeted molecular therapy is an effective anticancer strategy. Anti‐EGFR monoclonal antibodies such as cetuximab (CTX) have been approved for the treatment of various malignancies, including colorectal cancer (CRC) with wild‐type KRAS. However,